chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Chills, Dizziness, Headache, Migraine
Clinical narrative: MIGRAINE; CHILLS; HEADACHE; DIZZINESS; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers.  On 11-MAR-2021, the subject experienced migraine. On 11-MAR-2021, the subject experienced chills. On 11-MAR-2021, the subject experienced headache. On an unspecified date, the subject experienced dizziness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills, headache, migraine and dizziness was not reported. This report was non-serious.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: SORE ARM AFTER VACCINE; This spontaneous report received from a consumer via a company representative concerned a 50 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 04-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 04-MAR-2021, the subject experienced sore arm after vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of sore arm after vaccine was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Insomnia
Clinical narrative: UNABLE TO SLEEP; FELT AN ACHINESS ACROSS SHOULDERS; FELT CHILLED WHICH ONLY LASTED FOR ABOUT 20 MINUTES; FEELING TIRED; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, batch number were not reported, expiry: unknown) dose was not reported, administered on 10-MAR-2021 for prophylactic vaccination. The Batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the subject experienced unable to sleep, felt an achiness across shoulders, felt chilled which only lasted for about 20 minutes, and feeling tired. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from unable to sleep, felt chilled which only lasted for about 20 minutes, and feeling tired, and the outcome of felt an achiness across shoulders was not reported. This report was non-serious.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Insomnia, Nausea
Clinical narrative: TINNITUS; INSOMNIA; CHILLS; ACHINESS DOWN LEFT LEG; NAUSEA; HEADACHE; FEVER; This spontaneous report received from a patient concerned a 61 year old female. The patient's height, and weight were not reported. The patient's past medical history included degenerative disc, and concurrent conditions included osteoarthritis, non alcoholic, and non-smoker, and other pre-existing medical conditions included patient had no drug abuse or illicit drug usage. The patient experienced drug allergy when treated with ceclor. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805025, expiry: 25-MAY-2021) dose was not reported, administered on 10-MAR-2021 19:20 to left arm for prophylactic vaccination. No concomitant medications were reported. On 11-MAR-2021, the subject experienced chills. On 11-MAR-2021, the subject experienced achiness down left leg. On 11-MAR-2021, the subject experienced nausea. On 11-MAR-2021, the subject experienced headache. On 11-MAR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 100.1 F. On 12-MAR-2021, the subject experienced tinnitus. On 12-MAR-2021, the subject experienced insomnia. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, achiness down left leg, nausea, and fever on 11-MAR-2021, and had not recovered from tinnitus, headache, and insomnia. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure since case was assessed as non serious.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Tinnitus
Clinical narrative: TINNITUS; INSOMNIA; CHILLS; ACHINESS DOWN LEFT LEG; NAUSEA; HEADACHE; FEVER; This spontaneous report received from a patient concerned a 61 year old female. The patient's height, and weight were not reported. The patient's past medical history included degenerative disc, and concurrent conditions included osteoarthritis, non alcoholic, and non-smoker, and other pre-existing medical conditions included patient had no drug abuse or illicit drug usage. The patient experienced drug allergy when treated with ceclor. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805025, expiry: 25-MAY-2021) dose was not reported, administered on 10-MAR-2021 19:20 to left arm for prophylactic vaccination. No concomitant medications were reported. On 11-MAR-2021, the subject experienced chills. On 11-MAR-2021, the subject experienced achiness down left leg. On 11-MAR-2021, the subject experienced nausea. On 11-MAR-2021, the subject experienced headache. On 11-MAR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 100.1 F. On 12-MAR-2021, the subject experienced tinnitus. On 12-MAR-2021, the subject experienced insomnia. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, achiness down left leg, nausea, and fever on 11-MAR-2021, and had not recovered from tinnitus, headache, and insomnia. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure since case was assessed as non serious.
Sex: U
Vaccine: COVID19, UNK, COVID19
Symptoms: Lymphadenopathy
Clinical narrative: ENLARGED LYMPH NODES; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received ustekinumab (solution for infusion, route of admin not reported, batch number: Unk) dose, frequency, and therapy dates were not reported for an unspecified indication. The patient received covid-19 vaccine ad26.cov2.s (form of admin and route of admin were not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request natch/lot/numbers. No concomitant medications were reported. On an unspecified date, the subject experienced enlarged lymph nodes. The action taken with covid-19 vaccine ad26.cov2.s, and ustekinumab was not applicable. The outcome of enlarged lymph nodes was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19, UNK, COVID19
Symptoms: Aphasia, Cognitive disorder, Feeling abnormal, Gait disturbance, Gait inability
Clinical narrative: ENLARGED LYMPH NODES; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received ustekinumab (solution for infusion, route of admin not reported, batch number: Unk) dose, frequency, and therapy dates were not reported for an unspecified indication. The patient received covid-19 vaccine ad26.cov2.s (form of admin and route of admin were not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request natch/lot/numbers. No concomitant medications were reported. On an unspecified date, the subject experienced enlarged lymph nodes. The action taken with covid-19 vaccine ad26.cov2.s, and ustekinumab was not applicable. The outcome of enlarged lymph nodes was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19, UNK, COVID19
Symptoms: Motor dysfunction, Oligomenorrhoea
Clinical narrative: ENLARGED LYMPH NODES; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received ustekinumab (solution for infusion, route of admin not reported, batch number: Unk) dose, frequency, and therapy dates were not reported for an unspecified indication. The patient received covid-19 vaccine ad26.cov2.s (form of admin and route of admin were not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request natch/lot/numbers. No concomitant medications were reported. On an unspecified date, the subject experienced enlarged lymph nodes. The action taken with covid-19 vaccine ad26.cov2.s, and ustekinumab was not applicable. The outcome of enlarged lymph nodes was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Feeling abnormal, Flatulence, Flushing
Clinical narrative: DIARRHOEA; GAS; MUSCLE CRAMPS; HEADACHE; TIRED; WEIRD FEELING; FLUSHING BUT NOT FLUSHED; TINGLING OF FACE AND HANDS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included threw up, and concurrent conditions included high blood pressure, high cholesterol, sulfa drugs allergy, non-alcohol user, and non-smoker, and other pre-existing medical conditions included the patient not had any drug abuse / illicit drug use. the patient was non alcoholic and non smoker. The patient experienced drug allergy when treated with clindamycin, codeine, and azithromycin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, and batch number: 1805031 expiry: 26-MAY-2021) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-MAR-2021, the subject experienced weird feeling. On 12-MAR-2021, the subject experienced flushing but not flushed. On 12-MAR-2021, the subject experienced tingling of face and hands. On 12-MAR-2021, the subject experienced headache. On 12-MAR-2021, the subject experienced tired. On 14-MAR-2021, the subject experienced muscle cramps. On 16-MAR-2021, the subject experienced diarrhoea. On 16-MAR-2021, the subject experienced gas. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from diarrhoea on 16-MAR-2021, and headache on 14-MAR-2021, and had not recovered from weird feeling, flushing but not flushed, tired, tingling of face and hands, muscle cramps, and gas. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Muscle spasms, Paraesthesia
Clinical narrative: DIARRHOEA; GAS; MUSCLE CRAMPS; HEADACHE; TIRED; WEIRD FEELING; FLUSHING BUT NOT FLUSHED; TINGLING OF FACE AND HANDS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included threw up, and concurrent conditions included high blood pressure, high cholesterol, sulfa drugs allergy, non-alcohol user, and non-smoker, and other pre-existing medical conditions included the patient not had any drug abuse / illicit drug use. the patient was non alcoholic and non smoker. The patient experienced drug allergy when treated with clindamycin, codeine, and azithromycin. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, and batch number: 1805031 expiry: 26-MAY-2021) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-MAR-2021, the subject experienced weird feeling. On 12-MAR-2021, the subject experienced flushing but not flushed. On 12-MAR-2021, the subject experienced tingling of face and hands. On 12-MAR-2021, the subject experienced headache. On 12-MAR-2021, the subject experienced tired. On 14-MAR-2021, the subject experienced muscle cramps. On 16-MAR-2021, the subject experienced diarrhoea. On 16-MAR-2021, the subject experienced gas. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from diarrhoea on 16-MAR-2021, and headache on 14-MAR-2021, and had not recovered from weird feeling, flushing but not flushed, tired, tingling of face and hands, muscle cramps, and gas. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pain, Pyrexia
Clinical narrative: BODY ACHES; CHILLS; FEVER; MUSCLE PAIN; This spontaneous report received from a vaccine facility concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. The batch number was not reported and has been requested. On an unspecified date, the subject experienced body aches, chills, fever, and muscle pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, chills, muscle pain and body aches was not reported. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: HEADACHE; This spontaneous report received from a parent concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported,batch number: 1805022 expiry: UNKNOWN) dose was not reported, administered on 15-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 16-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of headache was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site pain, Mobility decreased, Nausea, Pain
Clinical narrative: CAN HARDLY MOVE; COMPLETE BODY ACHE; ARM HURT VERY BAD; FATIGUE; NAUSEA; FEVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included pancreatic cancer, sulfa allergy, penicillin allergy, narcotic allergy, codeine allergy, and macrobids allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025, and expiry: UNKNOWN) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination on left arm. No concomitant medications were reported. On 12-MAR-2021, the subject experienced can hardly move. On 12-MAR-2021, the subject experienced complete body ache. On 12-MAR-2021, the subject experienced arm hurt very bad. On 12-MAR-2021, the subject experienced fatigue. On 12-MAR-2021, the subject experienced nausea. On 12-MAR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on 14-MAR-2021, was recovering from can hardly move, and had not recovered from fatigue, complete body ache, nausea, and arm hurt very bad. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure since case was assessed as non serious.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: CAN HARDLY MOVE; COMPLETE BODY ACHE; ARM HURT VERY BAD; FATIGUE; NAUSEA; FEVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included pancreatic cancer, sulfa allergy, penicillin allergy, narcotic allergy, codeine allergy, and macrobids allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025, and expiry: UNKNOWN) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination on left arm. No concomitant medications were reported. On 12-MAR-2021, the subject experienced can hardly move. On 12-MAR-2021, the subject experienced complete body ache. On 12-MAR-2021, the subject experienced arm hurt very bad. On 12-MAR-2021, the subject experienced fatigue. On 12-MAR-2021, the subject experienced nausea. On 12-MAR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on 14-MAR-2021, was recovering from can hardly move, and had not recovered from fatigue, complete body ache, nausea, and arm hurt very bad. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure since case was assessed as non serious.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: FEVER; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow up to request batch/lot number. No concomitant medications were reported. On an unspecified date, the subject experienced fever. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 102 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of fever was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dyspnoea, Muscle spasms
Clinical narrative: SHORTNESS OF BREATH; LEG SPASMS; CHILLS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced shortness of breath, leg spasms, and chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from chills, shortness of breath, and leg spasms. This report was non-serious..
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: SORE ARM ON INJECTION SITE; This spontaneous report received from a consumer concerned a male of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) 1 in total, dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 11-MAR-2021, the subject experienced sore arm on injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from sore arm on injection site. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: HEADACHE; This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown expiry date: unknown) dose was not reported, administered on 15-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On mar-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of headache was not reported. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Dizziness, Feeling abnormal, Headache
Clinical narrative: ITCHY INJECTION SITE; SWOLLEN INJECTION SITE; RISE IN BLOOD PRESSURE; DIZZINESS; FOGGY; HEADACHE; FLU LIKE SYMPTOMS; This spontaneous report received from a patient concerned a 65 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802070 expiry: UNKNOWN) dose was not reported, administered on 08-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 08-MAR-2021, the subject experienced flu like symptoms. On 08-MAR-2021, the subject experienced headache. On 12-MAR-2021, the subject experienced rise in blood pressure. On 12-MAR-2021, the subject experienced dizziness. On 12-MAR-2021, the subject experienced foggy. Laboratory data included: Blood pressure (NR: not provided) 158/108 mmHg. On 14-MAR-2021, the subject experienced itchy injection site. On 14-MAR-2021, the subject experienced swollen injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu like symptoms on 10-MAR-2021, dizziness, foggy, and headache on MAR-2021, and itchy injection site, and swollen injection site on 14-MAR-2021, and had not recovered from rise in blood pressure. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Influenza like illness, Injection site pruritus, Injection site swelling
Clinical narrative: ITCHY INJECTION SITE; SWOLLEN INJECTION SITE; RISE IN BLOOD PRESSURE; DIZZINESS; FOGGY; HEADACHE; FLU LIKE SYMPTOMS; This spontaneous report received from a patient concerned a 65 year old female. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1802070 expiry: UNKNOWN) dose was not reported, administered on 08-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 08-MAR-2021, the subject experienced flu like symptoms. On 08-MAR-2021, the subject experienced headache. On 12-MAR-2021, the subject experienced rise in blood pressure. On 12-MAR-2021, the subject experienced dizziness. On 12-MAR-2021, the subject experienced foggy. Laboratory data included: Blood pressure (NR: not provided) 158/108 mmHg. On 14-MAR-2021, the subject experienced itchy injection site. On 14-MAR-2021, the subject experienced swollen injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from flu like symptoms on 10-MAR-2021, dizziness, foggy, and headache on MAR-2021, and itchy injection site, and swollen injection site on 14-MAR-2021, and had not recovered from rise in blood pressure. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Confusional state
Clinical narrative: CONFUSION; CHILLS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020, expiry: UNKNOWN) dose was not reported, administered on 17-MAR-2021 14:00 for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced confusion, and chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the chills and confusion was not reported. This report was non-serious.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose abnormal, Fatigue, Sensory loss
Clinical narrative: LOST FEELING IN LEGS; TOOK HIM DOWN; This spontaneous report received from a consumer concerned a 71 year old male. The patient's height, and weight were not reported. The patient's past medical history included prostate cancer, and concurrent conditions included diabetes insulin dependent, and other pre-existing medical conditions included patient had no known allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805029, and expiry: UNKNOWN) dose was not reported, administered on 12-MAR-2021 for prophylactic vaccination. Concomitant medications included insulin for diabetes. On 13-MAR-2021, the subject experienced lost feeling in legs. On 13-MAR-2021, the subject experienced took him down. Laboratory data (dates unspecified) included: Blood sugar abnormal (NR: not provided) 300 (not reported). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from lost feeling in legs, and took him down on 13-MAR-2021. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Application site pain, Blood culture, Body temperature, COVID-19, Culture urine
Clinical narrative: SEVERE PAIN BACK (BOTH SIDES-PELVIC AREA); CRAMPING ( LEFT ARM, RIGHT ARM, LEFT FINGERS, RIGHT UPER THIGHT, LEFT CAFT); BURNING EYES (SLIGHTLY); NAUSEA; FEVER; SORE ARM, INJECTION SITE; SINUS HEADACHE; ALL OVER BODY ACHES; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included postural orthostatic tachycardia, asthma, dysautonomia, celiac, gluten allergy, wheat allergy, mould allergy, tree allergy, alcohol use, and non-smoker.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, and batch number: 1805029 expiry: UNKNOWN) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 11-MAR-2021, the subject experienced sinus headache. On 11-MAR-2021, the subject experienced all over body aches. On 11-MAR-2021, the subject experienced fever. On 11-MAR-2021, the subject experienced sore arm, injection site. Laboratory data included: Body temperature (NR: 97.3 - 97.6) 101-103 F. On 12-MAR-2021, the subject experienced cramping ( left arm, right arm, left fingers, right uper thight, left caft). On 12-MAR-2021, the subject experienced burning eyes (slightly). On 12-MAR-2021, the subject experienced nausea. On 13-MAR-2021, the subject experienced severe pain back (both sides-pelvic area). On 16-MAR-2021, Laboratory data included: Urine culture (NR: not provided) POSITIVE (units unspecified). Laboratory data (dates unspecified) included: Blood culture (NR: not provided) Pending, and COVID-19 (NR: not provided) negative. Treatment medications (dates unspecified) included: ibuprofen, and oxycodone/paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from burning eyes (slightly), sinus headache, all over body aches, and fever on 15-MAR-2021, was recovering from sore arm, injection site, and nausea, and had not recovered from cramping ( left arm, right arm, left fingers, right uper thight, left caft), and severe pain back (both sides-pelvic area). This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Eye irritation, Muscle spasms, Nausea, Pain, Pelvic pain
Clinical narrative: SEVERE PAIN BACK (BOTH SIDES-PELVIC AREA); CRAMPING ( LEFT ARM, RIGHT ARM, LEFT FINGERS, RIGHT UPER THIGHT, LEFT CAFT); BURNING EYES (SLIGHTLY); NAUSEA; FEVER; SORE ARM, INJECTION SITE; SINUS HEADACHE; ALL OVER BODY ACHES; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included postural orthostatic tachycardia, asthma, dysautonomia, celiac, gluten allergy, wheat allergy, mould allergy, tree allergy, alcohol use, and non-smoker.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, and batch number: 1805029 expiry: UNKNOWN) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 11-MAR-2021, the subject experienced sinus headache. On 11-MAR-2021, the subject experienced all over body aches. On 11-MAR-2021, the subject experienced fever. On 11-MAR-2021, the subject experienced sore arm, injection site. Laboratory data included: Body temperature (NR: 97.3 - 97.6) 101-103 F. On 12-MAR-2021, the subject experienced cramping ( left arm, right arm, left fingers, right uper thight, left caft). On 12-MAR-2021, the subject experienced burning eyes (slightly). On 12-MAR-2021, the subject experienced nausea. On 13-MAR-2021, the subject experienced severe pain back (both sides-pelvic area). On 16-MAR-2021, Laboratory data included: Urine culture (NR: not provided) POSITIVE (units unspecified). Laboratory data (dates unspecified) included: Blood culture (NR: not provided) Pending, and COVID-19 (NR: not provided) negative. Treatment medications (dates unspecified) included: ibuprofen, and oxycodone/paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from burning eyes (slightly), sinus headache, all over body aches, and fever on 15-MAR-2021, was recovering from sore arm, injection site, and nausea, and had not recovered from cramping ( left arm, right arm, left fingers, right uper thight, left caft), and severe pain back (both sides-pelvic area). This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Sinus headache
Clinical narrative: SEVERE PAIN BACK (BOTH SIDES-PELVIC AREA); CRAMPING ( LEFT ARM, RIGHT ARM, LEFT FINGERS, RIGHT UPER THIGHT, LEFT CAFT); BURNING EYES (SLIGHTLY); NAUSEA; FEVER; SORE ARM, INJECTION SITE; SINUS HEADACHE; ALL OVER BODY ACHES; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included postural orthostatic tachycardia, asthma, dysautonomia, celiac, gluten allergy, wheat allergy, mould allergy, tree allergy, alcohol use, and non-smoker.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, and batch number: 1805029 expiry: UNKNOWN) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 11-MAR-2021, the subject experienced sinus headache. On 11-MAR-2021, the subject experienced all over body aches. On 11-MAR-2021, the subject experienced fever. On 11-MAR-2021, the subject experienced sore arm, injection site. Laboratory data included: Body temperature (NR: 97.3 - 97.6) 101-103 F. On 12-MAR-2021, the subject experienced cramping ( left arm, right arm, left fingers, right uper thight, left caft). On 12-MAR-2021, the subject experienced burning eyes (slightly). On 12-MAR-2021, the subject experienced nausea. On 13-MAR-2021, the subject experienced severe pain back (both sides-pelvic area). On 16-MAR-2021, Laboratory data included: Urine culture (NR: not provided) POSITIVE (units unspecified). Laboratory data (dates unspecified) included: Blood culture (NR: not provided) Pending, and COVID-19 (NR: not provided) negative. Treatment medications (dates unspecified) included: ibuprofen, and oxycodone/paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from burning eyes (slightly), sinus headache, all over body aches, and fever on 15-MAR-2021, was recovering from sore arm, injection site, and nausea, and had not recovered from cramping ( left arm, right arm, left fingers, right uper thight, left caft), and severe pain back (both sides-pelvic area). This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Application site bruise, Diarrhoea, Fatigue, Headache, Movement disorder
Clinical narrative: SORE THROAT; ARM BRUISING; DIARRHEA; HAND TREMORS; HARF TO OPEN AND CLOSE HAND; BODY ACHES; ARM SWELLING; HEADACHE; FATIGUE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient experienced drug allergy when treated with morphine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805029, and batch number: 1805029 expiry: UNKNOWN) dose was not reported, administered on 13-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-MAR-2021, the subject experienced arm bruising. On 13-MAR-2021, the subject experienced diarrhea. On 13-MAR-2021, the subject experienced hand tremors. On 13-MAR-2021, the subject experienced harf to open and close hand. On 13-MAR-2021, the subject experienced body aches. On 13-MAR-2021, the subject experienced arm swelling. On 13-MAR-2021, the subject experienced headache. On 13-MAR-2021, the subject experienced fatigue. On 16-MAR-2021, the subject experienced sore throat. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from hand tremors, and had not recovered from arm swelling, arm bruising, headache, diarrhea, body aches, fatigue, harf to open and close hand, and sore throat. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, Peripheral swelling, Tremor
Clinical narrative: SORE THROAT; ARM BRUISING; DIARRHEA; HAND TREMORS; HARF TO OPEN AND CLOSE HAND; BODY ACHES; ARM SWELLING; HEADACHE; FATIGUE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient experienced drug allergy when treated with morphine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 1805029, and batch number: 1805029 expiry: UNKNOWN) dose was not reported, administered on 13-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 13-MAR-2021, the subject experienced arm bruising. On 13-MAR-2021, the subject experienced diarrhea. On 13-MAR-2021, the subject experienced hand tremors. On 13-MAR-2021, the subject experienced harf to open and close hand. On 13-MAR-2021, the subject experienced body aches. On 13-MAR-2021, the subject experienced arm swelling. On 13-MAR-2021, the subject experienced headache. On 13-MAR-2021, the subject experienced fatigue. On 16-MAR-2021, the subject experienced sore throat. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from hand tremors, and had not recovered from arm swelling, arm bruising, headache, diarrhea, body aches, fatigue, harf to open and close hand, and sore throat. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Dyspnoea, Injection site swelling, Nausea, Pain in extremity
Clinical narrative: HARD TIME BREATHING; SPOT WHERE SHOT GIVEN IS RAISED AND BUMPY; CONSTANTLY NAUSEOUS; PAIN FROM ARM AND CAN'T MOVE IT; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 14-MAR-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot number. No concomitant medications were reported. On MAR-2021, the subject experienced hard time breathing. On MAR-2021, the subject experienced spot where shot given is raised and bumpy. On MAR-2021, the subject experienced constantly nauseous. On MAR-2021, the subject experienced pain from arm and can't move it. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the hard time breathing, constantly nauseous, pain from arm and can't move it and spot where shot given is raised and bumpy was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Adverse drug reaction, Feeling abnormal
Clinical narrative: GOT SIDE EFFECTS; FELT LIKE DYING; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 15-MAR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case.  No concomitant medications were reported. On MAR-2021, the subject experienced got side effects. On MAR-2021, the subject experienced felt like dying. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the got side effects and felt like dying was not reported. This report was non-serious. This case, from the same reporter is linked to 20210331319, 20210331262, 20210331801, 20210331104 and 20210332072.
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Arthralgia, Chills, Influenza like illness, Myalgia
Clinical narrative: FLU-LIKE SYMPTOMS; LOSS SENSE OF TASTE; CHILLS; JOINT PAIN; FEVER; MUSCLE ACHE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included diabetic, non alcohol user, and non smoker, and other pre-existing medical conditions included the patient did not have any drug abuse or illicit drug usage. The patient was previously treated with sulfamethoxazole/trimethoprim. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029) dose was not reported, once a total administered on 15-MAR-2021 15:00 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, treatment medications included: ibuprofen, and paracetamol. On 16-MAR-2021, the subject experienced flu-like symptoms. On 16-MAR-2021, the subject experienced loss sense of taste. On 16-MAR-2021, the subject experienced chills. On 16-MAR-2021, the subject experienced joint pain. On 16-MAR-2021, the subject experienced fever. On 16-MAR-2021, the subject experienced muscle ache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from chills, fever, muscle ache, joint pain, flu-like symptoms, and loss sense of taste. This report was non-serious.
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: FLU-LIKE SYMPTOMS; LOSS SENSE OF TASTE; CHILLS; JOINT PAIN; FEVER; MUSCLE ACHE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included diabetic, non alcohol user, and non smoker, and other pre-existing medical conditions included the patient did not have any drug abuse or illicit drug usage. The patient was previously treated with sulfamethoxazole/trimethoprim. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029) dose was not reported, once a total administered on 15-MAR-2021 15:00 for prophylactic vaccination. No concomitant medications were reported. On MAR-2021, treatment medications included: ibuprofen, and paracetamol. On 16-MAR-2021, the subject experienced flu-like symptoms. On 16-MAR-2021, the subject experienced loss sense of taste. On 16-MAR-2021, the subject experienced chills. On 16-MAR-2021, the subject experienced joint pain. On 16-MAR-2021, the subject experienced fever. On 16-MAR-2021, the subject experienced muscle ache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from chills, fever, muscle ache, joint pain, flu-like symptoms, and loss sense of taste. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Headache, Pain
Clinical narrative: BODY ACHES; CHILLS; BANGING SEVERE HEADACHE; FEVER; FATIGUE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's past medical history included covid.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. Batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported. On 11-MAR-2021, the subject experienced body aches. On 11-MAR-2021, the subject experienced chills. On 11-MAR-2021, the subject experienced banging severe headache. On 11-MAR-2021, the subject experienced fever. On 11-MAR-2021, the subject experienced fatigue. Laboratory data included: Body temperature (NR: not provided) 102.7. Treatment medications (dates unspecified) included: oxycodone/paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on 13-MAR-2021, and was recovering from banging severe headache, chills, body aches, and fatigue. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: BODY ACHES; CHILLS; BANGING SEVERE HEADACHE; FEVER; FATIGUE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's past medical history included covid.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. Batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported. On 11-MAR-2021, the subject experienced body aches. On 11-MAR-2021, the subject experienced chills. On 11-MAR-2021, the subject experienced banging severe headache. On 11-MAR-2021, the subject experienced fever. On 11-MAR-2021, the subject experienced fatigue. Laboratory data included: Body temperature (NR: not provided) 102.7. Treatment medications (dates unspecified) included: oxycodone/paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on 13-MAR-2021, and was recovering from banging severe headache, chills, body aches, and fatigue. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Headache, Myalgia, Vertigo
Clinical narrative: SEVERE VERTIGO; FATIGUE; MUSCLE ACHES; HEADACHE; SHORTNESS OF BREATH; This spontaneous report received from a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805018, and batch number: 1805018 expiry: UNKNOWN) dose was not reported, 1 total, administered on 12-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-MAR-2021, the subject experienced shortness of breath. On 13-MAR-2021, the subject experienced severe vertigo. On 13-MAR-2021, the subject experienced fatigue. On 13-MAR-2021, the subject experienced muscle aches. On 13-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from shortness of breath on 16-MAR-2021, and had not recovered from severe vertigo, fatigue, muscle aches, and headache. This report was non-serious.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Pyrexia
Clinical narrative: NAUSEA; HEADACHE; EXTREME TIREDNESS; FEVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient was not pregnant at the time of reporting.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805025, and batch number: 1805025 expiry: UNKNOWN) dose was not reported, administered on 10-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-MAR-2021, the subject experienced fever. On 11-MAR-2021, the subject experienced nausea. On 11-MAR-2021, the subject experienced headache. On 11-MAR-2021, the subject experienced extreme tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from nausea, fever, headache, and extreme tiredness on 15-MAR-2021. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Adverse event
Clinical narrative: UNSPECIFIED ADVERSE REACTION; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, and batch number: 1805031 expiry: UNKNOWN) dose, start therapy date were not reported for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the subject experienced unspecified adverse reaction. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of unspecified adverse reaction was not reported. This report was non-serious.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Chills, Headache, Pain, Pain in extremity
Clinical narrative: BODY ACHING; CHILLS; ARM SORENESS; SLIGHT HEADACHE TOWARDS THE BACK OF HEAD; FEVERISH; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, and expiry: UNKNOWN) dose was not reported, administered on 15-MAR-2021 14:30 on left arm for prophylactic vaccination. No concomitant medications were reported. On 16-MAR-2021, the subject experienced body aching. On 16-MAR-2021, the subject experienced chills. On 16-MAR-2021, the subject experienced arm soreness. On 16-MAR-2021, the subject experienced slight headache towards the back of head. On 16-MAR-2021, the subject experienced feverish. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 98.6 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from feverish, chills, arm soreness, body aching, and slight headache towards the back of head. This report was non-serious.